Jacinda Abdul-Mutakabbir, Pharm.D., MPH

Jacinda Abdul-Mutakabbir, Pharm.D., MPH

Loma Linda University

Jacinda Abdul-Mutakabbir, Pharm.D., MPH., is an assistant professor at Loma Linda School of Pharmacy in Loma Linda, California. She completed her doctorate in pharmacy at the University of Saint Joseph School of Pharmacy in Hartford, Connecticut. Following pharmacy school, she completed her pharmacy residency at the Howard University Hospital in Washington, D.C. She also completed an Infectious Disease Pharmacokinetics/ Pharmacodynamics (PK/PD) Research Fellowship under Dr. Michael J. Rybak Pharm.D., MPH, Ph.D., and earned a Master of Public Health at Wayne State University in Detroit, Michigan.

Dr. Abdul-Mutakabbir's research in mitigating antimicrobial resistance has led her to be recognized by the European Congress of Clinical Microbiology and Infectious Diseases as one of their 30 under 30 outstanding young scientists for the ECCMID 2021 31st annual meeting. 

Abdul-Mutakabbir is also dedicated to magnifying and rectifying health inequities in minoritized communities. She currently serves as the lead pharmacist and clinician for the Loma Linda University COVID-19 Equitable Mobile Vaccination Clinics. Her dedication to improving public health has been recognized by the United States Public Health Services, as she was the 2017 recipient of the USPHS Outstanding Service Award and named the awardee of the 2022 American Pharmacists Association-Immunization Champion (Honorable Mention) award. She was also the 2021 recipient of the Society of Infectious Disease Gita Patel Best Practice Award and the 2021 recipient of the Wayne State University Warrior of Distinction of Alumni Award. In addition, she was listed as one of the top 50 Most Influential Pharmacists in 2021 by the Pharmacy Podcast Network.

Abdul-Mutakabbir continues to be an active member of several professional organizations, including the American Society of Microbiology (ASM), Infectious Diseases Society of America (IDSA) and the Society of Infectious Disease Pharmacists (SIDP).